Increased concentrations of tirofiban in blood and their correlation with inhibition of platelet aggregation after greater bolus doses of tirofiban

This publication has 11 references indexed in Scilit:

• Enhanced early inhibition of platelet aggregation with an increased bolus of tirofiban
  The American Journal of Cardiology, 2002
• Platelet inhibition with tirofiban early during percutaneous coronary intervention: Dosing revisited
  Catheterization and Cardiovascular Interventions, 2002
• Comparison of degree of platelet inhibition by abciximab versus tirofiban in patients with unstable angina pectoris and non–Q-wave myocardial infarction undergoing percutaneous coronary intervention
  The American Journal of Cardiology, 2002
• Suboptimal early inhibition of platelets by treatment with tirofiban and implications for coronary interventions
  The American Journal of Cardiology, 2002
• Platelet Reactivity Characterized Prospectively
  Circulation, 2001
• Comparison of Two Platelet Glycoprotein IIb/IIIa Inhibitors, Tirofiban and Abciximab, for the Prevention of Ischemic Events with Percutaneous Coronary Revascularization
  New England Journal of Medicine, 2001
• Point-of-Care Measured Platelet Inhibition Correlates With a Reduced Risk of an Adverse Cardiac Event After Percutaneous Coronary Intervention
  Circulation, 2001
• Antiplatelet effects of abciximab, tirofiban and eptifibatide in patients undergoing coronary stenting
  Journal of the American College of Cardiology, 2001
• Role of Extracellular Ionized Calcium in the In Vitro Assessment of GPIIb/IIIa Receptor Antagonists
  Journal of Thrombosis and Thrombolysis, 2000
• Determination of MK-383, a non-peptide fibrinogen receptor antagonist, in human plasma and urine by radioimmunoassay
  Journal of Pharmaceutical and Biomedical Analysis, 1994